User menu

Di-n-butyltin(IV) derivatives of bis(carboxymethyl)benzylamines: synthesis, NMR and X-ray structure characterization and in vitro antitumour properties

  1. The antitumour activity of tin compounds. In Metal-Based Antitumour Drugs, vol. 1, (ed.). Freund Publ. House Ltd, London, 1988; 103-149.
  2. Organometallics in Cancer Chemotherapy. Main Group Metal Compounds, vol. 1. CRC Press, Boca Raton, FL, 1989.
  3. Gielen Marcel, Tin-based antitumour drugs, 10.1016/s0010-8545(96)90193-9
  4. de Vos, Met. Based Drugs, 5, 179 (1998)
  5. (ed.). Metal Complexes in Cancer Chemotherapy. VCH, Weinheim, 1993; 351-390.
  6. Meriem, J. Organomet. Chem., 365, 91 (1989)
  7. Gielen, Heteroat. Chem., 3, 449 (1992)
  8. Garrigues, Tetrahedron, 40, 1151 (1994)
  9. Mancilla, Heteroat. Chem., 5, 455 (1994)
  10. Mancilla, Polyhedron, 15, 3777 (1996)
  11. Mancilla, J. Organomet. Chem., 307, 1 (1986)
  12. Mancilla Teresa, Höpfl Herbert, Bravo Guadalupe, Carrillo Lourdes, CRYSTAL AND MOLECULAR STRUCTURE OF (N->B) PHENYL [N-METHYLIMINODIACETATE-O,O',N] BORANE, 10.1515/mgmc.1997.20.1.31
  13. Nardin, J. Chem. Soc. Dalton Trans., 369 (1980)
  14. Castineira, J. Coord. Chem., 30, 273 (1993)
  15. Rodgers, Inorg. Chim. Acta, 13, 163 (1975)
  16. Mootz, Acta Crystallogn. Sect. B, 36, 1189 (1980)
  17. Dakternieks, J. Organomet. Chem., 458, 29 (1993)
  18. Meriem, J. Organomet. Chem., 365, 91 (1989)
  19. Tzschach, J. Organomet. Chem., 193, 299 (1980)
  20. In vitro antitumour activity of organotin compounds. In Metal-Based Antitumour Drugs, vol. 2, (ed.) Freund Publ. House, Tel Aviv, 1992; 29-54.
  21. Unpublished results.
  22. HyperChem. Computational Chemistry, Version 5.02, 1996.
  23. Jeener, J. Chem. Phys., 71, 4546 (1979)
  24. Desvaux, J. Magn. Reson. A, 113, 47 (1995)
  25. (ed.). The Sadtler Handbook of Proton NMR Spectra. Heyden, London, 1978; 836-839.
  26. Holecek, J. Organomet. Chem., 315, 299 (1986)
  27. Gielen, Organometallics, 17, 4259 (1998)
  28. Willem, J. Organomet. Chem., 531, 151 (1997)
  29. (eds). Cancer: Principles and Practice of Oncology, 5th ed. Lippincott-Raven Publ., Philadelphia, 1997.
  30. Kepers, Eur. J. Cancer, 27, 897 (1991)
  31. Mosman, J. Immunol. Meth., 65, 55 (1983)
  32. Carmichael, Cancer Res., 47, 936 (1987)
  33. Keeler, Methods Enzymol., 239, 145 (1994)
  34. Willem, Organometallics, 15, 1920 (1996)
  35. Bou�lam, Main Group Met. Chem., 14, 41 (1991)
  36. TEXSAN: Structure Analysis Software. Molecular Structure Corp., The Woodlands, TX.
  37. Walker, Acta Crystallogr. Sect. A, 39, 158 (1983)
  38. The DIRDIF program system, Technical Report of the Crystallography Laboratory, University of Nijmegen, The Netherlands (1992).
  39. ORTEP. Report ORNL-5138, Oak Ridge National Laboratory, TN, 1976.
  40. Eti�vant, Anticancer Res., 11, 305 (1991)
  41. Darro, Cytometry, 14, 783 (1993)
  42. Darro, Gut, 36, 220 (1995)
Bibliographic reference Mancilla, T ; Carrillo, L ; Rivera, LSZ ; Camacho, CC ; De Vos, D. ; et. al. Di-n-butyltin(IV) derivatives of bis(carboxymethyl)benzylamines: synthesis, NMR and X-ray structure characterization and in vitro antitumour properties. In: Applied Organometallic Chemistry, Vol. 15, no. 7, p. 593-603 (2001)
Permanent URL http://hdl.handle.net/2078.1/42673